ADAM9 Promotes Glycolysis in Th17 Cells and Autoimmunity Through Activation of IGF ‐1 Signaling

Documenti analoghi

• Hypoxia Promotes the Expression of ADAM9 by Tubular Epithelial Cells, Which Enhances Transforming Growth Factor β1 Activation and Promotes Tissue Fibrosis in Patients With Lupus Nephritis
  di: Masataka Umeda, et al.
  Pubblicazione: (2024)
• Podocyte Interleukin‐23 Receptor Signaling in the Pathogenesis of Lupus Nephritis
  di: Rong Fu, et al.
  Pubblicazione: (2025)
• Aberrant Glycosylation of IgG in Children With Active Lupus Nephritis Alters Podocyte Metabolism and Causes Podocyte Injury
  di: Rhea Bhargava, et al.
  Pubblicazione: (2025)
• Efficacy and Safety of Sodium–Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events, and Safety Outcomes in Patients With Systemic Lupus Erythematosus and Comorbid Type 2 Diabetes: A Population‐Based Target Trial Emulation
  di: Kevin Sheng‐Kai Ma, et al.
  Pubblicazione: (2024)
• Precision Medicine in Pediatric Autoimmunity: Leniolisib Treatment of Childhood‐Onset Lupus Nephritis Due to Activated Phosphoinositide 3‐Kinase δ Syndrome
  di: Jonathan P. Lim, et al.
  Pubblicazione: (2025)